IL17A and gastric cancer: Secondly, IL-17A also activates the NF-κB/NADPH oxidase 1 (NOX1) signaling pathway by binding to IL-17RA and IL-17RC, and promotes the cell cycle transition from G1 to S phase, thereby promoting the proliferation of gastric cancer cells (80).